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Caloric restrictionAverage lifespan has increased over the last centuries, as a consequence of medical and environmental factors,
but maximal life span remains unchanged. Better understanding of the underlying mechanisms of aging and
determinants of life span will help to reduce age-related morbidity and facilitate healthy aging. Extension of
maximal life span is currently possible in animal models with measures such as genetic manipulations and
caloric restriction (CR). CR appears to prolong life by reducing oxidative damage. Reactive oxygen species
(ROS) have been proposed to cause deleterious effects on DNA, proteins, and lipids, and generation of these
highly reactive molecules takes place in the mitochondria. But ROS is positively implicated in cellular stress
defense mechanisms and formation of ROS a highly regulated process controlled by a complex network of
intracellular signaling pathways. There are endogenous anti-oxidant defense systems that have the potential
to partially counteract ROS impact. In this review, we will describe pathways contributing to the regulation of
the age-related decline in mitochondrial function and their impact on longevity. This article is part of a Special
Issue entitled Mitochondria: the deadly organelle.ondria: the deadly organelle.
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Within the last few hundred years, the average human lifespan has
increased substantially in theworld and transformed the demography
of most industrialized countries thanks to substantial improvements
in medical and environmental factors. In contrast to our achievements
in average lifespan, the maximal lifespan of humans remains
unchanged. The average lifespan continues to increase, largely due
to advances in preventive and therapeutic medicine, as well as
improvements in nutrition and technology. It appears that the
maximal life span may be genetically programmed or determined
by inevitable deleterious cellular changes that that occur with age.
These deleterious cellular changes typify the senescent phenotype,
leading eventually to death.
Many types of interventions, including genetic manipulations and
caloric restriction (CR), have been shown to increase the maximal life
span in animal models. However, it remains to be determined
whether the results from these elegant animal experiments will
eventually help to extend the human life span. Hypotheses have been
proposed to explain the biological processes regarding senescence,
and one important theory proposes that the formation of reactive
oxygen species (ROS) is the major generator of cellular damage and
senescence [1,2]. These deleterious effects from ROS could slowlyaccumulate over years and lead to dysfunction of several cellular
functions. The mitochondrion is the main organelle to produce ROS,
but as important as the energy generation in the mitochondrion is for
survival, the mitochondrial ROS production has some negative
consequences for age-related intracellular changes. However, ROS is
not only a waste of oxidative phosphorylation in the respiratory chain
but is also highly regulated signal molecules involved in cellular stress
response.
2. Mitochondrial function and ROS formation
The main role of mitochondria is to generate energy-rich
phosphate bonds in the form of adenosine triphosphate (ATP). This
ATP critical for several energy demanding processes in the cell, and
the mitochondria's crucial role in the cells homeostasis is obvious.
When carbon substrates enter the tricarboxylic acid cycle (TCA cycle),
nicotinamide adenine dinucleotide (NAD+) and ﬂavin adenine
dinucleotide (FAD) are reduced to NADH and FADH2 within the
matrix or through glycolysis in the cytosol, and promote electron ﬂow
though the respiratory chain. During the electron transfer process,
protons are released from complexes I, III, and IV to the intermem-
brane space, and a proton gradient is formed across the inner
membrane, and complex V (ATP synthase) harvests the energy from
this gradient to form ATP from ADP and P.
During the necessary oxygen-dependent ATP production in the
respiratory chain, there also is generation of reactive oxygen species
(ROS) as a natural byproduct. ROS are highly reactive molecules
containing valence shell electrons, as a product of electron leak in
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superoxide radical [3]. Superoxide will form hydrogen peroxide,
which is the major contributor to oxidative damage. ROS are
implicated in several important cell signaling pathways during
oxidative stress and can induce damage to DNA, amino acids in
proteins, and fatty acids. The close regional relationship between
mitochondrial ROS production and mitochondrial DNA (mtDNA) has
given inspiration to the mitochondrial free radical theory of aging [1]
(Fig. 1).
The mitochondrial free radical theory of aging, where ROS is
believed to be a detrimental byproduct from the respiratory chain
without any regulatory mechanism and that prompted, substantial
research by many investigators to identify the potential beneﬁcial
effects of antioxidant treatment. Some studies reveal no effect of
antioxidant treatment on health beneﬁcial outcomes as cancer [4,5],
diabetes [6] and cardiovascular disease [7], while other studies ﬁnd a
negative effect on outcome parameters as cancer [8–10] and life span
in humans [11,12]. One study has shown that glucose restriction
increases life span in C. elegans and that the underlying mechanism
behind this extension can be altered by antioxidant treatment (13). It
seems that ROS may have some advantageous effects on longevity by
inducing increased stress defense systems [13]. Furthermore, the
health beneﬁcial effect of exercise on insulin sensitivity and increased
endogenous antioxidant defense capacity is also impaired with
antioxidant treatment [14]. The increased defense against cellular
damage induced by low ROS levels is believed to reduce the overall
stress level and thereby be implicated in life span extension. A
favorable effect of a low dose of poison is called hormesis, and because
of the similarity to the beneﬁcial effect of ROS is this mechanism
named mitohormesis [15]. There are contradictory reports on theFig. 1. A proton gradient is formed over the inner mitochondrial membrane by the respirat
cycle, is crucial for complex IV to generate ATP from ADP+P. But during this process, single e
radicals are then converted to oxygen and water by SOD1–2 and catalase. Uncoupling protei
decrease the ROS formation.impact of exogenous antioxidants such as Vitamin C onmitochondrial
biogenesis and endogenous antioxidant defense stimulated by
exercise [16,17] and more deﬁnitive studies are needed to address
this issue.
3. Mitochondrial theory of aging
Mitochondria are unique organelles in the cell because they posses
their own DNA. Multiple copies of mitochondrial DNA (mtDNA) exist
within every mitochondrion and encode 2 ribosomal RNAs, 22
transfer RNAs and 13 proteins in the respiratory chain [18,19]. But
most mitochondrial proteins are encoded by the nuclear genome and
are actively transported to its location in the organelle. Unlike nuclear
DNA, mtDNA does not have histones, but form protein-DNA
complexes (nucleoids) in themitochondrial matrix [20]. This nucleoid
formation protects against oxidative damage, but not in the same way
as histones, and therefore mtDNA is more susceptible to ROS-
mediated damage than nuclear DNA. The damage to mtDNA consists
of modiﬁcations as 8-oxo-2'-deoxyguanosine [21], FapyG, FapyA
[22,23], and thymine glycol [24,25], which can lead to point mutations
[26,27], deletions [28], strand breaks [29,30], and block DNA
transcription and replication [24,25,31]. Any of these modiﬁcations
to mtDNA could be critical in the aging process, and it is evident that
oxidative damage to DNA increases with age, and perhaps leads to
increased mutations and deletions seen in senescence [32–34]. To
investigate whether these changes are a consequence of aging or
induce the aging process, investigators have employed knock-in mice
expressing a defective mitochondrial DNA polymerase. This knock-in
of the defective polymerase resulted in a ﬁvefold increase in levels of
point mutations and increased amounts of deleted mtDNA. Theory chain. This proton gradient, achieved by oxidizing NADH and FADH2 from the TCA
lectrons generate superoxide by interacting with oxygen at complexes I and III. The free
ns in the mitochondrial inner membrane can decrease the proton gradient and thereby
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onset of age-related alterations without increasing ROS levels [35,36].
These data support the notion that aging is a consequence of
mitochondrial modiﬁcations over time. Although these mutations in
the mitochondrial genome increase with age, the mutation rate may
not be high enough to cause any physiological effect [37]. Moreover,
the mRNA abundance of not only mitochondrial encoded genes, but
also those mitochondrial proteins encoded by the nuclear genes in
skeletal muscle are also reported to be reduced with age [32,38].
An accumulation of alterations in the displacement loop (D-loop)
[39–45], which controls mtDNA transcription and replication, could
cause the progressive decrease of mtDNA copy numbers observed
with age. In vitro studies have shown that oxidative damage also
causes mtDNA strand breaks which result in mtDNA degradation
[29,30,46,47]. Since mtDNA replication is regulated by transcription
factors encoded by nuclear DNA, it is critical that nuclear-mediated
replication in mitochondrial DNA occurs to maintain mtDNA
abundance. The decrease in mtDNA abundance occurs in sedentary
people and may be responsible for reduced mRNA abundance of
mitochondrial encoded proteins, possibly in a tissue speciﬁc manner
[32,38,48,49]. The mRNA abundance does not always correlate to
protein synthesis, but it is evident that the mitochondrial protein
synthesis rate is reduced with aging [38,50–53]. It is not known how
the protein degradation rate is regulated, but the mitochondrial Lon
protease is reduced with aging [54], and indirect evidence fromwhole
body measurements support the possibility of reduced degradation of
proteins with aging [55]. This could slow the clearance rate of non-
functional mitochondrial proteins and thereby be the cause of
impaired function of several mitochondrial proteins and overall
mitochondrial function [48,49,53]. Aging-related decreased protein
turnover could further lead to increased ROS exposure time, causing
the elevated levels of damaged proteins through carbonylation and
nitrotyrosylation [56–58].
Not all studies ﬁnd this decline in muscle mitochondrial function
with aging [59–64]. ATP production has been extensively used to
asses overall mitochondrial function with aging, and several investi-
gators have observed an inverse relationship between age and ATP
production [32,65–67], but this observation is not consistent
[63,64,68–70]. The reason for these discrepancies is not entirely
clear, but differences in activity levels and relatively small numbers of
participants studied may explain the differences (Fig. 2).
4. Caloric restriction, exercise and extension of life span
Caloric restriction (CR) has been known for 75 years to extend
lifespan in rodents [71], and it is currently the only known non-
pharmacological intervention with this effect. The prolongation of
lifespan has been examined in a variety of species, and the effect of CR
is conserved across a broad range of species, from yeast to rats [72].
There are still no data in humans, but there are ongoing studies of CR
in monkeys. The primary outcome on longevity of these monkeys is
yet to be revealed, but the preliminary data indicate a beneﬁcial effect
on age-related changes such as insulin resistance [73,74], atheroscle-
rosis [75], oxidative damage [76], cancer, and age-related mortality
[77]. Although no human studies comparable to animals have been
performed, Holloszy's group has reported that people who deliber-
ately follow a CR diet for a long period and maintain their weight at a
low level have several beneﬁcial effects. They have low levels of
inﬂammation markers, including C-reactive protein and tumor
necrosis factor-α, low LDL and high HDL in serum, and 40% reduction
of carotid artery intima-media thickness as a marker of reduced
atherosclerosis [78]. Left ventricular diastolic stiffness is reduced,
suggesting a lower level of ﬁbrosis in the heart [79]. Furthermore,
insulin sensitivity indexes are signiﬁcantly higher in the CR group
compared to controls on western diet [80]. However, it remains to be
determined whether these people live longer or may succumb todiseases such as pulmonary infection and die of respiratory failure as
has been observed in other frail people.
Exercise increased mitochondrial content and capacity [81]
through increased expression of mitochondrial proteins encoded by
nuclear and mitochondrial genomes [82]. Furthermore, mtDNA copy
number is also signiﬁcantly increased by exercise training inmice [82]
and humans [38]. Endurance exercise give rise to beneﬁcial adapta-
tions in human muscle on factors impaired with aging. These changes
are also evident in trained elderly people, like young people increase
their maximal oxygen consumption, mitochondrial content, and
enzyme activity [83–85]. The age-dependent decline of mtDNA copy
number and mitochondrial proteins persist despite a high aerobic
exercise level, but at a higher expression level in trained subjects [38].
The exercise-induced improvement in mitochondrial function is
similar to the effect seen by CR, and it seems likely that exercise can
help delay the onset of many age-related mitochondrial changes, but
it remains to be determined if it has any impact on lifespan.
Because of the reduced oxidative damage reported in CR animals,
we conducted studies to examine the effect on mitochondria in rats.
CR increased transcripts of genes involved in ROS scavenging, tissue
development, and energy metabolism, while decreased expression of
genes involved in signal transduction, stress response and structural
and contractile proteins [86]. High fat diet had the opposite effect of
CR by reducing expression of genes involved in ROS scavenging [87].
The diet-induced alterations in transcripts involved in ROS scavenging
underline that mitochondria could contribute to regulation of
longevity and to understand the regulation of these mechanisms, a
greater detail of mitochondrial function and ROS regulation is needed.
5. Uncoupling proteins
ROS production is dependent on the mitochondrial membrane
potential, ΔΨ. High mitochondrial membrane potential will induce a
greater potential for backﬂow of electrons in the respiratory chain, and
this increases the ROS production because of the electron leak in
complex I and complex III [3,88,89]. The mitochondrial membrane
potential is partly regulated by uncoupling proteins, UCP1-3 (UCP1 in
brown adipose tissue [90] UCP2 is broadly expressed [91–93] and UCP3
is highly expressed in skeletal muscle tissue [94,95]). Uncoupling
proteins are located in the inner membrane and shuttle protons from
the intermembrane space to the matrix, before they pass complex IV to
form ATP. This shuttle function decreases ROS production by reducing
the membrane potential [96,97]. But ROS are also shown to increase
proton conductance over themitochondrial membrane by activation of
mammalianUCPs [98–100], and it is a possibility that this is a regulatory
mechanism to decrease the abundance of free radicals and their effects
in the cell. It seems that UCPs can play a role in the regulation of
mitochondrial membrane potential and thereby be a key factor of ROS
generation, and this is the basics of the “uncoupling-to-survive”
hypothesis [101]. According to the hypothesis, uncoupling ATP
synthesis from oxygen consumption has an important role in the
regulation of aging, and has been supported by several studies over the
last decade. UCP3 abundance decreases with aging [102] and knockout
increases markers of oxidative stress in mice [103,104], while over-
expression causes a blunted age increased ROS production [105].
Experimental evidence of a positive correlation between longevity and
uncoupling of proton ﬂux was found in a comparison of mice from the
upper and lower quartile ofmetabolic intensity.Metabolic intensitywas
calculated as the ratio daily food intake per body weight and showed
that higher metabolic intensity is associated with a signiﬁcantly longer
lifespan, higher oxygen consumption in rest, and a higher uncoupling in
the mitochondria of the upper quartile [106]. However, this approach
has important limitations because the body weight includes both
metabolically active and inactive (e.g., triglyceride stores) tissues. Even
when adjusted for lean tissue, there are limitations related to the
variability ofmetabolic activity in different lean tissues of the body (e.g.,
Fig. 2. The free radical theory of aging: ROS formation leads to damagedmitochondrial DNA and proteins. The ROS-induced damage reduces mitochondrial function and lifespan. This
reduction in mitochondrial function with aging can be prevented by CR and can prolong lifespan in several species.
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the correlation to uncoupling and lifespan supports a hypothesis that
individual mice with higher metabolism have greater mitochondrial
uncoupling and longer life. This hypothesis opposes the notion that
reducing oxidative metabolism reduces the ﬂux of electrons across the
electron transport chain, with a consequent decrease in ROS production
that may occur in CR. However, it supports the notion that increasing
oxidative metabolism causes a greater ﬂux of electrons through the
electron transport chain, with a consequent decrease in ROS production
[107]. CR is well known for its ability to prolong lifespan in several
species, and is proven to increasemRNAexpression and protein content
of UCP2–3 in mice [108,109]. It is possible to mimic the increased
longevity effect of CR by treating mice with the uncoupling agent 3,4-
dinitrophenol, which decreased ROS production and oxidative damage
[110]. By overexpression of human UCP2 in ﬂy neurons, it has been
demonstrated thatROSproduction is decreasedandoxidative damage is
reduced, together with increased state 4 respiration as a marker of
increased proton leak. These transgenic ﬂies also have signiﬁcant
prolongation of lifespan [111]. These observations were extended in
mouse overexpression and knockout models. One study reported that
UCP2 knockout is correlated with a signiﬁcantly lower lifespan than
control WT mice [112], while another study reported no effect of UCP2
andUCP3knockouton altering longevity [113]. Themeansurvival age in
these transgenic mice was not increased by overexpression of human
UCP2alone, but the combinationof overexpressionbothUCP2 andUCP3
cause a slight increase in mean survival. This increase in mean survival
was not accompanied by increase in maximal lifespan as seen in CR
[113]. The fact that CR is increasing UCP2 and UCP3 but transgenic
overexpression lacks the increase in maximal lifespan talks against a
direct role of UCPs in this process.6. ROS scavenging
When themitochondrial innermembrane potential is high enough
to induce ROS production, the antioxidant superoxide dismutase
(SOD) is responsible for the enzymatic process of converting
superoxide to hydrogen peroxide, 2O2−+2H+ → H2O2+O2. This
dismutation reaction makes it possible for catalase, glutathione
peroxidase, and peroxiredoxins to catalyze the degradation of
hydrogen peroxide to water and oxygen, H2O2→H2O+O2. SOD is
found in two compartment-speciﬁc isoforms; copper-zinc superoxide
dismutase (ZnSOD, SOD1) and manganese superoxide dismutase
(MnSOD, SOD2). SOD1 is responsible for superoxide consumption in
the cytosol and extracellular matrix while SOD2's catalytic activity
takes place in the mitochondrial matrix [89]. These dismutation
enzymes make it possible for the cell to harvest the energy yield from
the proton gradient without the potential damaging effect of ROS
production. A link between cellular ROS abundance and longevity has
been investigated in several studies with manipulation of the oxidant
scavenging system. Slowing of telomere shortening has been reported
in cultured ﬁbroblasts when superoxide dismutase is elevated [114],
and in this is also evident in relatively shortlived [115], but not long-
lived strains of Drosophila melanogaster when superoxide dismutase
and catalase are overexpressed [116]. Moreover, elevated expression
of superoxide dismutase and catalase are present in the long-lived
AGE-1 mutants of Caenorhabditis elegans compared to normal
[117,118]. It seems that enhancing antioxidant capacity is capable of
signiﬁcantly prolonging the lifespan in several species, but decreasing
the capacity has given conﬂicting results. Knockdown of copper–zinc
superoxide dismutase induces senescence in human ﬁbroblasts [119].
In mice knockout models there are, however, conﬂicting results: some
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dismutase 1 or 2 show no alteration on lifespan [120–122], while
others ﬁnd signiﬁcant reduction with knock out of superoxide
dismutase 2 [123]. The reduced lifespan by knockout of SOD2 can
be counteracted by overexpression of human UCP2, probably because
of reduced need for the enzymatic dismutation process when the
UCP2-induced proton leak reduces membrane potential [112].
7. P66Shc and ROS generation
There will, however, always be some degree of oxidative damage
particularly in mitochondrial proteins, lipids, and DNA, independent
of antioxidant buffering capacity. The oxidative stress is also evident
from elevated oxidation levels in proteins (carbonylation), lipids
(peroxidation), and DNA in older humans [124]. The superoxide
production rate is generally regarded as having a constant positive
relationship with oxygen consumption, but since the ROS production
is dependent on membrane potential, this relationship is presumably
more complex. As mentioned earlier, the membrane potential is
regulated by several mechanisms, and furthermore ROS is also
produced by other sources than the backward ﬂow of electrons in
the respiratory chain. It is now evident that it is not only the direct
damaging effect of ROS on DNA, proteins, and lipids, but also a highly
regulated interaction of ROS on distinctive signaling pathways related
to aging.
The majority of ROS production is created as a consequence of
backward electron ﬂow in the respiratory chain, but the 66 kda
isoform of Shc (p66Shc) does function as an oxidoreductase and
shuttles electrons to molecular oxygen to form superoxide [125], and
cultivated p66Shc knock out cells have reduced ROS formation and
damage [125–127]. P66Shc is shown to be a critical factor in
programmed cell death, and targeted mutation of the gene in mice
is correlated to increased stress resistance and prolonged lifespan.
Furthermore, mouse embryo ﬁbroblasts from p66Shc knockout mice
are resistant to apoptosis under oxidative stress [128]. In mammals,
the proto-oncogene Shc is expressed in three isoforms; 46, 52 and 66
kDa [129]. All isoforms interact with tyrosine-phosphorylated
proteins on the cytosolic domain of growth factor receptors, where
they, upon activation, are phosphorylated and form complexes with
Grb2 [130–132]. The 66 kDa isoform does not activate the signal in the
Ras, Raf-1, MAPK pathway as the other isoforms, but is rather a
competitive antagonist [133–136]. About 1/5 of p66Shc is in close
contact with mitochondria in ﬁbroblasts, but because of translocation,
this ratio increases during oxidative stress [137]. The serine residue on
position 36 (ser36) in the N-terminal domain of p66Shc is
phosphorylated as a critical post-translational activation site upon
oxidative stress [138]. After phosphorylation and translocation the
protein is bound to a complex with heat shock protein 70 (HSP70),
and this binding destabilizes by pro-apoptopic stimuli, and the
monomeric active form of p66Shc is released [137,139]. In the
mitochondria, reduction of oxygen can then be mediated by p66Shc
binding to cytochrome c. This interaction shuttles electrons to oxygen
and forms free radicals [125]. These modiﬁcations are independent of
membrane potential and create ROS in a regulated pattern.
Moreover p66Shc is an essential downstream target of p53 stress-
induced elevation of oxidants, cytochrome release, and apoptosis, and
p53 increases p66Shc protein levels by enhancing stability [127].
Consequently, it seem like p53-p66Shc is a sensor of oxidative damage
andhigh intensity oxidative signals anddrives the cell against apoptosis.
The activation of these pathways induces an increased probability
of outer mitochondrial membrane permeabiliazation as a conse-
quence of the increased ROS levels [125]. Normally, cytochrome c
forms a complex with the anionic phospholipid cardiolipin in the
mitochondrial inner membrane, but during oxidative stress cardioli-
pin will be peroxidized and the afﬁnity for cytochrome c decreased.
The lower afﬁnity will release cytochrome c from its membranelocalization and impair the respiratory chain, mediating electron
backﬂow and an increase in the ROS production rate. This increased
ROS production will further increase the oxidation of cardiolipin and
amplify the oxidative damage to the mitochondria [140–142]. As a
part of this process, the inner membrane becomes permeable to
cytochrome c, as a consequence of mitochondrial transition pore
opening and concomitant swelling of the organelle [125]. The
abundance of cytochrome c in cytoplasm is one of the factors that
trigger apoptosis. The formation of a complex called apoptosome
comprised of cytochrome c, Apaf-1, and procaspase 9 in the cytosol,
will activate procaspase 9, and this will induce further downstream
activation of caspases executing the apoptotic degradation of DNA and
proteins in the cell [142–144].
8. FOXO-mediated cell survival
P66Shc is not only interacting in the redox activity of the cell by its
function as oxidoreductase but is also interacting in this system by
inhibiting forkhead/winged helix box gene group O (FOXO)-induced
transcription of ROS scavenging enzymes [126]. FOXO is a highly
conserved group of transcription factors involved in a wide range of
adaptations to oxidative and metabolic stress. The FOXO family
consists of four genes in mammals (FOXO1, FOXO3, FOXO4 and
FOXO6) [145,146]. This family of transcription factors is expressed in a
wide range of tissues and binds to TTGTTTAC recognition motif [147].
In invertebrates, the FOXO transcription factor induces prolongation
of lifespan [148–151], and in mammals, the protein family is involved
in detoxiﬁcation of reactive oxygen species [126], tumor suppression
[152], energy metabolism [153,154], erythroid differentiation [155],
and myogenesis [156]. Furthermore, FOXO3 is genetically associated
with longevity in humans [157,158]. They induce the effect via
promotion of ROS scavenging enzymes [126,159], cell cycle arrest
[152], DNA repair [160], and apoptosis [148,161]. Overexpression of
FOXO1 in muscle tissue is, however, not capable of altering longevity
in transgenic mice [162]. The activity of these transcription factors is
primarily dependent on subcellular location, and this is regulated by a
broad range of post-translational modiﬁcations: phosphorylations,
acetylations and ubiquitinations. These regulation mechanisms are
highly complex and sometimes directly antagonistic (Fig. 3).
The insulin/IGF-1, PI3K, Akt pathway is, to a large extent, involved
in lifespan regulation. Suppression of the pathway increases lifespan,
and upregulation shortens lifespan in a broad range of species [163].
Insulin and IGF-I receptors vary signiﬁcantly amongst mammals and
indicate a more complicated regulation of lifespan than in many other
species. It has been shown that IGF-1 and insulin have different
impacts on lifespan modulation [164]. Upregulating glucose signaling
shortens lifespan in C. elegans [165], while downregulation of the
signal transduction bymutation of daf-2 (insulin/IGF-1 receptor gene)
in nematodes doubles their lifespan [166], and a mutation in the same
receptor can increase the lifespan in Drosophila melanogaster up to
80% [167]. A similar lifespan extension is seen in mice with decreased
IGF-1 signaling [168,169], and increased SOD and catalase are
observed as downstream effects of the reduced IGF-I signal [128].
Downstream from the insulin/IGF-1 receptor, the active phosphory-
lated form of AKT is crucial in the negative regulation of FOXO3, via
exclusion of the transcription factors from the nucleus [148,149,170].
Insulin and insulin-like growth factors induce phosphorylation on
FOXO3 (T32 and S253) [170,171] via Akt, and this generates a binding
site for the chaperone 14-3-3 [172]. The binding of chaperones further
promotes active transport of the complex out of the nucleus, probably
via a conformational change that helps expose the FOXO nuclear
export sequence [173]. The phosphorylation is not only responsible
for export of the transcription factors to the cytoplasm but also
prevents re-entry to the nucleus via introduction of a negative charge
in the residues that accounts for the FOXO nuclear localization signal,
and by alterations in the ﬂexibility of the same region [174]. The
Fig. 3. FOXO transcription factors need DNA contact to induce transcription of target
genes, and the activity is primarily dependent on subcellular location. AKT-dependent
phosphorylation mediates export from the nucleus, while AMPK phosphorylation on
other amino acid residues activates transcription. Acetylation inactivates FOXO
transcription, while deacetylation by sirt1 and sirt3 has the opposite effect.
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compartmentation, but also the Akt-dependent phosphorylation of
FOXO1 (S256; equivalent to FOXO3ser253) which reduces the positive
charge in the DNA-binding domain. The DNA-binding is compromised
in in vitro binding assays through this change in charge [175,176].
Additionally, EAK-7 is also shown to inhibit FOXO transcriptionwithout
inﬂuencing subcellular localization [177].
As mentioned above, p66shc interacts in FOXO transcriptional
regulation of ROS scavenging enzymes. In p66shc−/− ﬁbroblasts, the
phosphorylation of FOXO3 (T32 and S253) is inhibited after oxidative
stress, and therefore FOXO inhibition is dependent on active p66shc
after oxidative stress in wild-type ﬁbroblasts [126]. Furthermore, the
binding of FOXO to the promoter region of the catalase gene is regulated
via this pathway, which is consistent with studies demonstrating that
the FOXO3 induces MnSOD expression [126,159], and the FOXO
homolog DAF-16 is a transcription factor for several antioxidant
scavenger genes (SOD, catalase and OLD-1) in C. elegans [178,179].
FOXO transcription factors are not only negatively regulated
through phosphorylation but are also activated by phosphorylation
on other amino acid residues. Under periods with low energy
availability, AMP activated protein kinase (AMPK) is activated. This
is due to formation of AMP as a consequence of the of the reduced ATP
generation from the respiratory chain. The allosteric activator AMP
binds to the γ-subunit of AMPK and induces a conformational change
that activates the catalytic α-subunit [180]. AMP activated AMPK
induces phosphorylation on all four isoforms of FOXO, with a
preference for FOXO3[181]. The phosphorylation of FOXO3 leads
upregulated transcriptional activity. This AMPK-dependent upregula-
tion is due to phosphorylation on several sites in mammalian cells; in
vitro FOXO3 T179, S399, S413, S555, S588, and S626, and in vivo S413
and S588 [181]. The activation of FOXO by AMPK increases the
expression of speciﬁc target genes involved in stress resistance and
energy balance. This AMPK-dependent activation does not upregulate
transcription in all FOXO3 target genes, but is more selective to energy
adaptation genes, and it seems not to regulate FOXO1 in the sameway
[181,182]. During caloric restriction, AMPK extends the lifespan inC. elegans via activation of the forkhead transcription factor DAF-16
[183], and this could be an important pathway in response to caloric
restriction in several species.
The post-translational regulation of FOXO transcription factors is,
as mentioned above, not only through phosphorylation, but acetyla-
tion also plays a signiﬁcant role in the activity regulation. The
opposing action of acetylases and deacetylases is a continuous
process. The acetylase involved in the regulation of FOXO is cyclic
response element (CREB)-binding protein (CBP) [184], while the
deacetylation is mediated via the NAD-dependent class III deacetylase
silent information regulator T1 (sirt1) [185,186]. The DNA-binding
ability of FOXO3 is reduced by the CBP acetylation of lysin residue 245,
and the AKT-induced phosphorylation of S253 on FOXO1 is enhanced
when the protein is acetylated [187,188]. Overall, acetylation is
enhancing and interacting with AKT phosphorylation-induced inhi-
bition of FOXO, while sirt1 deacetylation enhances FOXO activity.
9. Sirtuins: SIRT1 and SIRT3 important factors in longevity
Sirtuins (named from silent mating-type information regulating
two (Sir2) in yeast) are a class of proteins that act as deacetylases or
mono-ribosyltransferases and have a highly conserved catalytic
groove from E. coli to humans [189]. While sirt1 inhibits FOXO- and
p53-induced apotosis [186], FOXO3 and p53 promote increased sirt1
expression during nutrient deprivation. This increase in sirt1
transcription is achieved by two p53 binding sites in the sirt1
promoter, after physical interaction between FOXO3 and p53 [190].
The family of sirtuins is expressed in a variety of mammalian
tissues and consists of sevenmembers, sirt1–7, where sirt1 is themost
extensively studied [191]. Sirt1–3 and -5 catalyze lysine deacetylation
on target proteins, via cleavage of NAD+ into nicotinamide (NAM)
and 1-O-acetyl-ADP-ribose [192,193]. NAD+ hydrolysis is essential for
the reaction, and this dependency of sirtuins on NAD+ links the
catalytic activity directly to energy balance. This dependency of NAD+
abundance on enzymatic activity makes sirt1 and -3 act as a fuel-
sensing regulators of metabolic adaptations to nutrient deprivation
[194]. NAM is a NAD+ antagonist, by binding to the catalytic core
domain of sirtuins [195]. CR increases activity of the NAM salvage
pathway, which will reduce the abundance of NAM and increases the
abundance of NAD+. The decrease in NAM is induced by the
nicotinamidase PNC1 in yeast, which has been shown to highly
regulate lifespan [195–197], and consistent with this is that PNC1
homologs in ﬂies and worms also correlated to longevity [198,199]. In
higher eukaryotes, the rate-limiting enzyme in the NAM salvage
pathway, NAMPT, is also shown to regulate NAD+ levels and thereby
sirtuin activity in human cell lines [200,201]. Sirtuin activity is not
only regulated by NAD+ and NAM levels, but sirt1 activity is also
inhibited by direct binding of DBC1 in the catalytic grove in in vitro
[202] and in in vivo [203] . It is evident that reduced binding of DBC1
to sirt1, signiﬁcantly increased deacetylase activity after starvation in
mice, but not much is known about the regulation of this interaction
[203]. Sirt1 deacetylation of p53 is upregulated by complex formation
with AROS [204] and Necdin [205].
Furthermore, sirt1 activity is also regulated by post-translational
modiﬁcations, such as sumoylations and phosphorylations. Mutation
of the sirt1 sumoylation site lysine 734 or desumoylation by SENP1
reduces the deacetylase activity, and cells depleted of SENP1 have
improved resistance to stress-induced apoptosis. This indicates that
sumoylation is an important post-translational modiﬁcation that
increases sirt1 activity in cells and thereby prevents acetylation and
activation of apoptotic proteins [206]. Interaction of cJUN N-terminal
kinase (JNK1) and sirt1 induces phosphorylation on three sites of
sirt1; Ser27, Ser 47 and Thr530. These phosphorylation sites were
shown to increase enzymatic activity via deacetylation of histone H3,
but not p53, which further illustrates the complex regulation of this
pathway [207].
Fig. 4. AMPK increases transcription of PNC1/NAMPT during metabolic stress and
thereby increases NAD+ and further increases sir2/sirt1 activity. Activated sir2/sirt1
deacetylates the upstream AMPK kinase LKB1, which further increases AMPK activity.
This interdependency is crucial in mitochondrial biogenesis through increased PGC1α
expression and activity.
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Sirt1-induced increase in FOXO transcription activity does not include
all FOXO target genes, like AMPK activation. Sirt1 induces cell cycle
arrest by transcriptional silencing though physical modiﬁcation of DNA
due to histone deacetylation [194]. Sirt1 increase expression of genes
involved in stress resistance, including the FOXO target gene MnSOD
[209], and inhibits the pro-apoptopic FOXO target genes BIM and
FAS [186]. Sirt1 is not only inhibiting FOXO-induced apoptosis but
is also downregulating the p53-induced apoptosis via deacetylation
[210–212]. Furthermore, sirt1 deacetylation of two critical lysine
residues on the DNA repair factor Ku70 improves the binding of Ku70
to Bax, which is involved in the initiation of apoptosis. The formation of
the Ku70/Bax complex keeps Bax away from the mitochondria and
thereby increases cell survival [213]. This parallel inhibition of FOXO-,
p53-, and Bax-induced apoptosis, and enhanced expression of cell cycle
arrest and stress resistance genes is vital for sirt1's ability to enhance
lifespan in a wide range of organisms.
Activation of Sirt1 does not only affect mitochondria via increased
resistance to oxidative stress and inhibition of apoptosis but also
directly interacts withmitochondrial biogenesis. As mentioned above,
sirt1 and AMPK exhibit cross-talk on FOXO transcription factors,
which is not surprising since these two proteins posses energy
sensing properties. This cross-talk is also present in mitochondrial
biogenesis, where the interaction between proteins can potentiate
reciprocal activity. The upstream activator of AMPK liver kinase B1
(LKB1) is deacetylated on lysine 48 by sirt1, thereby mediating
migration from the nucleus to the cytosol [214]. As already described,
AMPK is activated by AMP-binding on the γ-subunit during metabolic
stress, but this activation is dependent on LKB1 [215,216] or calcium/
calmodulin kinase kinase-β (CaMKKβ) [217] phosphorylation of
AMPK threonine residue 172 on the α-catalytic subunit [218]. LKB1
is the primary upstream AMPK kinase, which increases activity in
response to energy deprived states. Alternatively, AMPK is capable of
activating sirt1 by upregulating NAMPT and thereby increasing NAD+
and decrease NAM [219]. An important factor in mitochondrial
biogenesis is PGC1α, and it has been shown that sirt1 deacetylation of
PGC1α increase target gene expression in a NAD+-dependent manner
[220]. Furthermore deacetylation of PGC1α by sirt1 was shown to
improve mitochondrial function in mice, with signiﬁcant increase in
aerobic capacity [221], and this regulation is dependent on AMPK
[222]. The increased mitochondrial function by sirt1–PGC1α is
achieved by upregulation of genes for oxidative phosphorylation
and mitochondrial biogenesis [221] (Fig. 4). Indeed, sirt1 induces
transcription of mitochondrial fatty acid oxidative genes via PGC1α
deacetylation [223]. There has recently been identiﬁed an interaction
of sirt1, PGC1α, and mitochondrial transcription factor A (TFAM) in
close proximity to the D-loop of mtDNA recognized by TFAM [224].
This suggests that the sirt1–PGC1α interaction is highly involved in
both nuclear and mitochondrial transcription of DNA and may
represent a similar regulation and cross-talk of the nuclear and
mitochondrial genome.
Another protein in the sirtuin family is the mitochondrial sirt3
[225]. It is not as well investigated as sirt1 but is also associated with
longevity. While sirt1 has been shown to regulate lifespan in a
number of species, sirt3 is the only sirtuin genetically linked to
longevity in humans [226], and its abundance decreases with age [38].
This decrease can partly be counter acted by exercise [38].
Sirt3−/− mice have a higher risk of developing mammary tumors
[227]; however, they have no signs of other disorders compared to
their wild-type controls under normal conditions [228]. But during
oxidative stress, ROS production increases and ATP levels decrease in
sirt3−/− cardiomyocytes [229], and sirt3 has also been shown to
decrease hypertrophic signaling in the cardiomyocytes, via inhibition
of AKT in a sirt3-LKB1-AMPK dependent manner during NAD+
treatment in mice [230]. During fasting sirt3−/− transgenic mice
have hyperacetylated long-chain acyl coenzyme A dehydrogenase(LCAD) on lysine 42 and thereby reduced levels of fatty acid
oxidation and accumulation of fatty acid intermediates in the liver.
This sirt3-dependent regulation of lipid metabolism could be
responsible for the decrease in ATP production in sirt3−/− transgenic
mice [231]. Sirt3 could be an important factor in regulating ROS
abundance, since it promotes FOXO3 transport to the nucleus where
the transcription factor as already mentioned, increases the produc-
tion of MnSOD and catalase [232]. Increased ROS levels correlate to a
gradual decrease in the integrity of mtDNA in livers from sirt3−/−
mice at 20, 36 and 58 weeks, and it has been shown that sirt3 acts as
a tumor suppressor [227]. Sirt3's suppression of tumor formation
goes well together with the observation that sirt3−/− mice develop
mammary tumors.
10. Summary and conclusions
The biology of aging remains to be fully understood. Here, we
review the mitochondrial interaction with pathways and potential
mechanisms that cause damage to DNA, proteins, and tissues with
aging. The effect of CR appears to be related to reduction of ROS-
induced cellular damage. There is increasing evidence that chronic
exercise can counteract the age-related decline in mitochondrial
DNA abundance and functions besides preserving the expression of
SIRT3, which is a longevity gene. Reducing caloric intake and
preventing excessive accumulation of adipose tissue and regular
exercise programs have many beneﬁcial effects that may extend the
average life span and contribute to healthy aging. However, like CR,
exercise also remains to be demonstrated as a measure to extend life
span. Further studies in human and animal models of the various
longevity pathways are needed to determine whether human life
span can be extended while maintaining relatively normal functions
of organs.
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